HEADER HORMONE/GROWTH FACTOR 14-DEC-01 1KMF TITLE NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALLO-ILE, HIS-B10-ASP, TITLE 2 PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: INSULIN; COMPND 8 CHAIN: B; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE SOURCE 4 OF THE PEPTIDE IS NATURALLY FOUND IN HOMO SAPIENS (HUMAN).; SOURCE 5 MOL_ID: 2; SOURCE 6 SYNTHETIC: YES; SOURCE 7 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE SOURCE 8 OF THE PEPTIDE IS NATURALLY FOUND IN HOMO SAPIENS (HUMAN). KEYWDS HORMONE, HUMAN INSULIN, MUTANT, HORMONE-GROWTH FACTOR COMPLEX EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR B.XU,Q.X.HUA,S.H.NAKAGAWA,W.JIA,Y.C.CHU,P.G.KATSOYANNIS,M.A.WEISS REVDAT 4 27-OCT-21 1KMF 1 REMARK SEQADV LINK REVDAT 3 24-FEB-09 1KMF 1 VERSN REVDAT 2 06-MAR-02 1KMF 1 JRNL REVDAT 1 09-JAN-02 1KMF 0 JRNL AUTH B.XU,Q.X.HUA,S.H.NAKAGAWA,W.JIA,Y.C.CHU,P.G.KATSOYANNIS, JRNL AUTH 2 M.A.WEISS JRNL TITL CHIRAL MUTAGENESIS OF INSULIN'S HIDDEN RECEPTOR-BINDING JRNL TITL 2 SURFACE: STRUCTURE OF AN ALLO-ISOLEUCINE(A2) ANALOGUE. JRNL REF J.MOL.BIOL. V. 316 435 2002 JRNL REFN ISSN 0022-2836 JRNL PMID 11866509 JRNL DOI 10.1006/JMBI.2001.5377 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.KITAGAWA,H.OGAWA,G.T.BURKE,J.D.CHANLEY,P.G.KATSOYANNIS REMARK 1 TITL CRITICAL ROLE OF THE A2 AMINO ACID RESIDUE IN THE BIOLOGICAL REMARK 1 TITL 2 ACTIVITY OF INSULIN: [2-GLYCINE-A]- AND REMARK 1 TITL 3 [2-ALANINE-A]INSULINS REMARK 1 REF BIOCHEMISTRY V. 23 1405 1984 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 2 REMARK 1 AUTH S.H.NAKAGAWA,H.S.TAGER REMARK 1 TITL IMPORTANCE OF ALIPHATIC SIDE-CHAIN STRUCTURE AT POSITIONS 2 REMARK 1 TITL 2 AND 3 OF THE INSULIN A CHAIN IN INSULIN-RECEPTOR REMARK 1 TITL 3 INTERACTIONS REMARK 1 REF BIOCHEMISTRY V. 31 3204 1992 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 3 REMARK 1 AUTH Q.X.HUA,S.Q.HU,B.H.FRANK,W.JIA,Y.C.CHU,S.H.WANG,G.T.BURKE, REMARK 1 AUTH 2 P.G.KATSOYANNIS,M.A.WEISS REMARK 1 TITL MAPPING THE FUNCTIONAL SURFACE OF INSULIN BY DESIGN: REMARK 1 TITL 2 STRUCTURE AND FUNCTION OF A NOVEL A-CHAIN ANALOGUE REMARK 1 REF J.MOL.BIOL. V. 264 390 1996 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.1996.0648 REMARK 1 REFERENCE 4 REMARK 1 AUTH B.XU,Q.X.HUA,S.H.NAKAGAWA,W.JIA,Y.C.CHU,P.G.KATSOYANNIS, REMARK 1 AUTH 2 M.A.WEISS REMARK 1 TITL A CAVITY-FORMING MUTATION IN INSULIN INDUCES SEGMENTAL REMARK 1 TITL 2 UNFOLDING OF A SURROUNDING ALPHA-HELIX REMARK 1 REF PROTEIN SCI. V. 11 104 2002 REMARK 1 REFN ISSN 0961-8368 REMARK 1 DOI 10.1110/PS.PS.32102 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DGII INSIGHTII 2000, X-PLOR 3.85 REMARK 3 AUTHORS : MOLECULAR SIMULATIONS INC. (DGII), BRUNGER (X REMARK 3 -PLOR) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURE IS BASED ON A TOTAL OF REMARK 3 599 RESTRAINTS, 542 ARE NOE-DERIVED DISTANCE CONSTRAINTS, 38 REMARK 3 DIHEDRAL ANGLE RESTRAINTS, 19 DISTANCE RESTRAINTS FROM HYDROGEN REMARK 3 BONDS. REMARK 4 REMARK 4 1KMF COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-DEC-01. REMARK 100 THE DEPOSITION ID IS D_1000015108. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298; 305 REMARK 210 PH : 7.0; 7.6 REMARK 210 IONIC STRENGTH : NULL; NULL REMARK 210 PRESSURE : AMBIENT; AMBIENT REMARK 210 SAMPLE CONTENTS : 1.2 MM ALLO-ILE-A2-DKP-INSULIN; REMARK 210 90% H2O, 10% D2O; 1.2 MM ALLO- REMARK 210 ILE-A2-DKP-INSULIN; 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY; DQF-COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : DISTANCE GEOMETRY AND SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 CYS A 11 -149.17 -99.96 REMARK 500 1 CYS A 20 -100.57 -88.00 REMARK 500 1 CYS B 7 -103.50 -140.53 REMARK 500 1 GLU B 21 -75.98 -70.22 REMARK 500 1 PHE B 24 162.54 176.19 REMARK 500 2 SER A 9 -155.92 -155.34 REMARK 500 2 CYS A 20 -95.56 -91.30 REMARK 500 2 CYS B 7 -105.95 171.87 REMARK 500 2 PHE B 24 168.32 176.79 REMARK 500 2 TYR B 26 170.34 -48.76 REMARK 500 3 CYS A 11 -154.12 39.75 REMARK 500 3 CYS B 7 -105.26 166.65 REMARK 500 3 ARG B 22 -31.85 -39.29 REMARK 500 3 PHE B 24 123.15 58.25 REMARK 500 3 TYR B 26 106.59 -40.53 REMARK 500 4 SER A 9 -150.74 -155.15 REMARK 500 4 ILE A 10 -141.26 -86.19 REMARK 500 4 CYS A 11 137.21 169.31 REMARK 500 4 CYS A 20 -98.50 -90.54 REMARK 500 4 CYS B 7 -107.95 -166.44 REMARK 500 4 GLU B 21 -77.94 -89.47 REMARK 500 4 PHE B 24 165.73 176.50 REMARK 500 4 LYS B 28 68.94 -162.68 REMARK 500 5 IIL A 2 -43.06 -135.10 REMARK 500 5 GLN A 5 -67.00 -105.19 REMARK 500 5 SER A 9 -159.96 -169.78 REMARK 500 5 CYS A 11 -136.07 -110.10 REMARK 500 5 CYS A 20 -95.16 -98.88 REMARK 500 5 ASN B 3 22.55 -161.53 REMARK 500 5 CYS B 7 -104.23 -158.45 REMARK 500 5 GLU B 21 -65.35 65.52 REMARK 500 5 PHE B 24 -175.10 44.61 REMARK 500 5 PHE B 25 109.53 -160.77 REMARK 500 5 LYS B 28 80.54 -158.29 REMARK 500 6 CYS A 11 -157.59 -150.30 REMARK 500 6 CYS A 20 -95.98 -73.03 REMARK 500 6 CYS B 7 -108.35 -162.74 REMARK 500 6 CYS B 19 61.85 -113.27 REMARK 500 6 GLU B 21 -75.11 -70.69 REMARK 500 6 PHE B 24 167.97 174.65 REMARK 500 6 LYS B 28 70.98 -152.03 REMARK 500 7 SER A 9 -167.95 -160.23 REMARK 500 7 CYS A 11 -161.61 -111.53 REMARK 500 7 CYS A 20 -95.19 -91.80 REMARK 500 7 ASN B 3 -22.39 167.47 REMARK 500 7 CYS B 7 -109.50 -159.89 REMARK 500 7 CYS B 19 -82.11 -102.61 REMARK 500 7 PHE B 24 147.64 176.11 REMARK 500 8 SER A 9 -150.04 -135.12 REMARK 500 8 CYS A 11 141.63 80.56 REMARK 500 REMARK 500 THIS ENTRY HAS 104 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 1 ARG B 22 0.10 SIDE CHAIN REMARK 500 2 ARG B 22 0.30 SIDE CHAIN REMARK 500 3 ARG B 22 0.30 SIDE CHAIN REMARK 500 4 ARG B 22 0.31 SIDE CHAIN REMARK 500 5 ARG B 22 0.23 SIDE CHAIN REMARK 500 6 ARG B 22 0.30 SIDE CHAIN REMARK 500 7 ARG B 22 0.25 SIDE CHAIN REMARK 500 8 ARG B 22 0.28 SIDE CHAIN REMARK 500 9 ARG B 22 0.30 SIDE CHAIN REMARK 500 10 ARG B 22 0.28 SIDE CHAIN REMARK 500 11 ARG B 22 0.16 SIDE CHAIN REMARK 500 12 ARG B 22 0.27 SIDE CHAIN REMARK 500 13 ARG B 22 0.31 SIDE CHAIN REMARK 500 14 ARG B 22 0.24 SIDE CHAIN REMARK 500 15 ARG B 22 0.30 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1K3M RELATED DB: PDB REMARK 900 1K3M CONTAINS THE SAME SEQUENCE EXCEPT SUBSTITUTION OF ILE-A2-ALA DBREF 1KMF A 1 21 UNP P01308 INS_HUMAN 87 107 DBREF 1KMF B 1 30 UNP P01308 INS_HUMAN 25 54 SEQADV 1KMF IIL A 2 UNP P01308 ILE 88 ENGINEERED MUTATION SEQADV 1KMF ASP B 10 UNP P01308 HIS 34 ENGINEERED MUTATION SEQADV 1KMF LYS B 28 UNP P01308 PRO 52 ENGINEERED MUTATION SEQADV 1KMF PRO B 29 UNP P01308 LYS 53 ENGINEERED MUTATION SEQRES 1 A 21 GLY IIL VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 A 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 B 30 PHE VAL ASN GLN HIS LEU CYS GLY SER ASP LEU VAL GLU SEQRES 2 B 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 B 30 THR LYS PRO THR MODRES 1KMF IIL A 2 ILE ISO-ISOLEUCINE HET IIL A 2 19 HETNAM IIL ISO-ISOLEUCINE HETSYN IIL ALLO-ISOLEUCINE FORMUL 1 IIL C6 H13 N O2 HELIX 1 1 IIL A 2 CYS A 7 1 6 HELIX 2 2 SER A 12 CYS A 20 1 9 HELIX 3 3 SER B 9 CYS B 19 1 11 SSBOND 1 CYS A 6 CYS A 11 1555 1555 2.02 SSBOND 2 CYS A 7 CYS B 7 1555 1555 2.02 SSBOND 3 CYS A 20 CYS B 19 1555 1555 2.02 LINK C GLY A 1 N IIL A 2 1555 1555 1.30 LINK C IIL A 2 N VAL A 3 1555 1555 1.30 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1